The Analgesic Efficacy of Perineural Nalbuphine as an Adjuvant to Bupivacaine in Ultrasound Guided Superficial Cervical Plexus Nerve Block for Thyroid Surgeries. A Double Blinded Randomized Controlled Trial.

NCT06633068 Phase 2 RECRUITING

This study aiming to evaluate the analgesic effect of adding nalbuphine as an adjuvant to bupivacaine in superficial cervical plexus block during thyroid surgeries regarding first rescue analgesia in the first twenty-four hours postoperative, VAS score after extubation and complications such as postoperative nausea, vomiting and respiratory depression.

Details

Lead sponsor	Cairo University
Phase	Phase 2
Status	RECRUITING
Enrolment	54
Start date	2024-07-15
Completion	2025-07

Conditions

• Intra and Postoperative Pain Management

Interventions

• Adding perineural Nalbuphine to Bupivacaine in superficial cervical nerve block

Primary outcomes

• time to first rescue analgesia (will be given to VAS score > 4) following surgery in the first 24 hours. — First 24 hours postoperative
  defined as the time interval between the end of surgery and the first request to postoperative Nalbuphine

Countries

Egypt